Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-31 @ 5:53 AM
Study NCT ID:
NCT05253833
Status:
COMPLETED
Last Update Posted:
2025-01-29
First Post:
2022-02-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
Sponsor:
Arthrosi Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-15
First Submit QC Date:
None
Study First Post Date:
2022-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-11-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-01-27
Last Update Post Date:
2025-01-29
Last Update Post Date Type:
ACTUAL